Table 1

Summary characteristics of ongoing trials of RIC in stroke

ParameterNo of studies
Study populationIschaemic stroke/TIA31
Symptomatic intracranial stenosis8
Aneurysmal subarachnoid haemorrhage4
Unruptured cerebral aneurysm3
Intracerebral haemorrhage3
Timing of conditioningRIPreC3
RIPerC and early RIPostC28
Chronic RIPostC16
Unspecified1
Participants (N)<10024
100–50017
501–10004
>10003
RIC protocolCuff pressure180 mm Hg2
200 mm Hg26
225 mm Hg2
20 mm Hg >SBP4
30 mm Hg >SBP2
50 mm Hg >SBP1
110 mm Hg >SBP1
Variable1
Unspecified9
Cycle length3 min1
5 min36
10 min1
Variable1
Unspecified9
Cycle frequency35
416
519
Variable1
Unspecified7
LimbUpper36
Lower5
Unspecified7
Unilateral18
Bilateral16
Unspecified14
Study locationAsia30
Europe10
North America8
Primary outcome measuresClinicalmodified Rankin Scale6
Compliance/feasibility6
Adverse events6
Recurrent stroke4
Combined vascular events1
All-cause mortality1
NIHSS1
Walking speed1
Depression incidence1
Blood samplesSerum biomarkers5
Immune profile2
Coagulation profile1
RadiologicalInfarct size/growth6
New infarcts2
Cerebral blood flow/collateral circulation3
Vasospasm2
Flow-mediated dilatation1
OtherP300 event-related potential1
Cardiac function (echocardiogram)1
Estimated study completion201911
202010
20218
20225
20230
20243
  • RIC, remote ischaemic conditioning; RIPerC, Remote ischaemic perconditioning; RIPostC, Remote ischaemic postconditioning; RIPreC, Remote ischaemic preconditioning; SBP, systolic blood pressure; TIA, Transient Ischaemic Attack.